PSMA1 and neoplasm: Similarly, YC-273-IRDye800CW, PSMA-1-IRDye800CW, PSMA-1-Cy5.5, and SCE-IRDye800CW have been established and preliminarily validated in PSMA+ PCa tumor-bearing mice 92-94.